-       Report 
- February 2023
-  66 Pages 
- North America 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- February 2023
-  75 Pages 
- Middle East, Africa 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- February 2023
-  75 Pages 
- Europe 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- February 2023
-  76 Pages 
- Asia Pacific 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- November 2019
- China 
   From       €7151EUR$7,995USD£6,290GBP 
           -       Book 
- August 2025
- North America 
               -       Book 
- November 2024
- North America 
                        Urolithiasis, also known as urinary stone disease, is a condition in which stones form in the urinary tract. It is a common condition in urology and nephrology, and is caused by a variety of factors, including diet, genetics, and lifestyle. Symptoms of urolithiasis can include pain, difficulty urinating, and blood in the urine. Treatment options include medications, dietary changes, and surgical procedures.
The urolithiasis market is composed of a variety of products and services, including    medications, medical devices, and surgical procedures. Companies in the market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples of companies in the market include AstraZeneca, Boston Scientific, and Fresenius Medical Care. Show Less   Read more